NCT00094874

Brief Summary

Acupuncture is a form of Chinese medicine that has been in existence for more than a thousand years. This clinical trial performs two types of acupuncture on traditional 'bladder' points to determine if one type demonstrates improvement over the other. In the first type needles stimulate acupuncture points on the skin, and in the second type the needles penetrate through the skin similar to how acupuncture is usually performed. The technique is done through shields so that people will not know what type of acupuncture they receive. Patients must have at least moderately severe disease as determined by a urologist. They must be willing not to change their medical regimen for the duration of the trial. Patients will receive twelve treatments over six to twelve weeks. They will be asked to fill out symptom questionnaires and bladder diaries at regular intervals to monitor change. All treatment is free of charge, and patients who complete the trial will receive a small stipend.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Sep 2004

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2004

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 27, 2004

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 28, 2004

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2005

Completed
Last Updated

June 24, 2005

Status Verified

October 1, 2004

First QC Date

October 27, 2004

Last Update Submit

June 23, 2005

Conditions

Keywords

pelvic pain, bladder pain, urgency, frequency, nocturia

Outcome Measures

Primary Outcomes (1)

  • Rate of improvement between arms as indicated by a Patient Overall Rating of Improvement Scale

Secondary Outcomes (3)

  • Improvement in Interstitial Cystitis Symptom and Problem Indices (validated symptom-specific measures)

  • Improvement in University of Wisconsin-Interstitial Cystitis Scale (validated symptom-specific measure)

  • Improvement in frequency, urgency and nocturia as measured on bladder diaries

Interventions

AcupuncturePROCEDURE

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65 years
  • Symptomatic IC for at least six months
  • Urinary frequency of at least eleven voids in a 24 hour period
  • A self-rated global discomfort score of 4 or greater on a 0-10 scale

You may not qualify if:

  • Medical History or Co-Morbid Conditions:
  • Any history of: bladder calculus, tuberculous cystitis; neurological disease or diabetic cystopathy; malignant bladder tumors, urethral cancer
  • Prior 3 years of uterine, cervical or vaginal cancer (women only)
  • Prior 6-12 weeks of: bacterial urinary tract infection; active genital herpes; gross hematuria
  • Concurrent active urethral calculus, ureteral calculus, symptomatic urethral diverticulum; documented chronic bacterial prostatitis (men only); active vaginitis, pregnancy (women only)
  • Prior and Concurrent Treatment for IC:
  • Any history of: cyclophosphamide, pelvic radiation; augmentation cystoplasty, cystectomy or cystolysis, neurectomy, implanted peripheral nerve stimulator; prostate surgery or treatment (men only)
  • In the prior 24 weeks: any treatment with intravesical BCG, cystocele, rectocele, urinary incontinence surgery, transvaginal surgery, hysterectomy, prolapse, vaginal delivery or C-section (women only)
  • Prior 6-12 weeks: any treatment by urethral dilatation, cystometrogram, urodynamics, cystoscopy/hydrodistention, bladder biopsy; prostate biopsy (men only); any intravesical treatment other than BCG
  • Prior 4 weeks: any new medications initiated for IC
  • Concurrent intravesical heparin, chronic use of acetylsalicylic acid, non-steroidal anti-inflammatory drugs or opioid pain medications for another pain condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pennsylvania Pain Medicine Center

Philadelphia, Pennsylvania, 19104, United States

RECRUITING

MeSH Terms

Conditions

Cystitis, InterstitialPelvic PainNocturia

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

CystitisUrinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsLower Urinary Tract SymptomsUrological Manifestations

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 27, 2004

First Posted

October 28, 2004

Study Start

September 1, 2004

Study Completion

September 1, 2005

Last Updated

June 24, 2005

Record last verified: 2004-10

Locations